Member Info for Richob

A bit of MSC background from the MS Society:

https://www.mssociety.org.uk/research/explore-our-research/emerging-research-and-treatments/stem-cells/mesenchymal-stem-cell-therapy

Onwards Avacta.

Excellent find, gadgie.

Looks like Stonebridge have now invested twice in Affyxell.

There's more in theses MSC therapies than we know I reckon and the manufacturer is lined up and also invested.

Sounds promising.

Onwards Avacta.

MCB,

Not sure that LSE accurately display buys and sells.

I also thought the SP would be going up as the trades came in but what would any of us know?

Can't be shenigans as this is always dismissed as nonsense.

As soon as we know that AVA600 improves the therapeutic index of doxorubicin we will see this go upwards without a doubt.

Onwards Avacta.

Late reporting doesn't really matter as the MMs know at the time of the trade.

Just my opinion of course.

Onwards Avacta.

For a cancer cure with no side effects it actually sounds a bit low.

Onwards Avacta.

Why is that, doggy?

...and Sujood did say August, Timster.

Exciting isn't it?

Onwards Avacta.

Cheers and yes, Timster.

It was the toxicity comparisons that caught my eye. I had read of 18 times but not as high as those numbers.

Onwards Avacta.

https://aacrjournals.org/cancerres/article/82/12_Supplement/1815/700880

Some interesting toxicity comparisons between AVA6000 and doxorubicin.

Onwards Avacta.

https://www.withpower.com/trial/phase-1-sarcoma-6-2021-6f477

This must be DE (in my opinion).

We know that this is "up to three" tumour types and that pancreatic was the first and we also know that Glasgow has previously asked for head and neck volunteers and is now asking for breast cancer volunteers.

I may be joining up too many dots but for all those with any of the above this would be amazing news.

Onwards Avacta.

https://www.withpower.com/trial/phase-1-sarcoma-6-2021-6f477

Pretty sure this said "head and neck" the other week.

First I have seen about breast cancer.

Happy to be corrected.

Onwards Avacta.

Not a bad article about FAP:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586189/

Even mentions pro drugs.

Onwards Avacta.

I think they have eligibility criteria to cover known issues as well, Mr A.

Onwards Avacta.

Sorry.

FAPI PET Imaging Avacta.

For some reason I can't get a link but if you type FAPI PET imaging into Google and scroll down a little there is a pdf from Avacta last year covering TMAC etcetera, which may help and is very interesting anyway.

All the best.

Onwards Avacta.

Only four hours of it though.

... another one here:

https://www.biopharminternational.com/view/lg-chem-renews-license-with-avacta-for-ind-studies

Onwards Avacta.

https://www.cambridgenetwork.co.uk/news/affyxell-successfully-completes-funding-round

I think we sometimes forget about the multiple other shots that Avacta has on goal and some go off on pointless tangents of course. You wonder why but such is life.

Just my opinion of course.

Onwards Avacta.

What is more likely to move the SP is more people discovering the company and its potential and the actual progress it is making, which is actually quite outstanding.

Onwards Avacta.